Dr. Gerald Grant graduated magna cum laude with a Bachelor of Arts degree from Duke University in 1989 and then completed his medical education at Stanford University School of Medicine in 1994. Dr. Grant is currently an Associate Professor of Neurosurgery and by courtesy, Neurology at Stanford University Medical Center. He was previously tenured faculty at Duke University in the Preston Robert Tisch Brain Tumor Center and was recruited to Stanford in 2013 to be Division Chief of Pediatric Neurosurgery. Dr. Grant is a member of the Stanford Cancer Institute, Stanford Neurosciences Institute, Bio-X, and Child Health Research Institute at Stanford. He is a Diplomat of the American Board of Neurological Surgery and is also board certified in Pediatric Neurosurgery by the American Board of Pediatric Neurological Surgery.
He has a specialized clinical interest in Chiari malformations, pediatric brain tumors, epilepsy, and trauma. His laboratory efforts focus on molecular characterization of the blood-tumor barrier and tumor microenvironment and was previously funded by the AANS (NREF grant) as well as a Career Development Award from the NCI (Spore-Duke) and currently directs a translational blood-brain barrier laboratory funded by the NIH (NINDS). Dr. Grant also collaborates closely with several biomedical engineers at Stanford to study small molecule drug conjugates. Dr. Grant is the Stanford Principal Investigator for the Park Reeves Chiari Syringomyelia Consortium.
Dr. Grant was elected to the Executive Committee of the Congress of Neurological Surgeons, the Joint Section of Pediatric Neurosurgery, and the American Association of Pediatric Neurosurgeons. He is also currently Publications Chair, Editor-In-Chief of Clinical Neurosurgery and Congress Quarterly, and Pediatric Section Editor for Neurosurgery. He is a new member of the CSF Scientific and Educational Advisory Board.
